Carnitine-deficient myopathy as a presentation of tyrosinemia type I

被引:4
作者
Nissenkorn, A
Korman, SH
Vardi, O
Levine, A
Katzir, Z
Ballin, A
Lerman-Sagie, T
机构
[1] Wolfson Med Ctr, Metab Neurogenet Serv, IL-58100 Holon, Israel
[2] Wolfson Med Ctr, Pediat Gastroenterol Unit, IL-58100 Holon, Israel
[3] Wolfson Med Ctr, Pediat Nephrol Unit, IL-58100 Holon, Israel
[4] Wolfson Med Ctr, Dept Pediat, IL-58100 Holon, Israel
[5] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[6] Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel
[7] Maccabi Hlth Serv, Child Dev Ctr, Rishon Leziyyon, Israel
关键词
D O I
10.1177/088307380101600903
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Carnitine deficiency secondary to renal Fanconi's tubulopathy has been described in only a few inborn errors of metabolism: cystinosis, galactosemia, and Fanconi-Bieckel syndrome. We report a 27-month-old infant who presented with a sudden change in gait owing to proximal muscle weakness. The laboratory evaluation showed carnitine deficiency associated with Fanconi's tubulopathy. Eventually, tyrosinemia type I was diagnosed. Carnitine deficiency can contribute to the clinical picture of hepatorenal tyrosinemia and should therefore be evaluated and treated.
引用
收藏
页码:642 / 644
页数:3
相关论文
共 16 条
[1]   PLASMA AND MUSCLE FREE CARNITINE DEFICIENCY DUE TO RENAL FANCONI SYNDROME [J].
BERNARDINI, I ;
RIZZO, WB ;
DALAKAS, M ;
BERNAR, J ;
GAHL, WA .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) :1124-1130
[2]   CARNITINE DEFICIENCY SYNDROMES [J].
BRENINGSTALL, GN .
PEDIATRIC NEUROLOGY, 1990, 6 (02) :75-81
[3]   PLASMA-CONCENTRATIONS OF TRANSSULFURATION PATHWAY PRODUCTS DURING NASOENTERAL AND INTRAVENOUS HYPERALIMENTATION OF MALNOURISHED PATIENTS [J].
CHAWLA, RK ;
BERRY, CJ ;
KUTNER, MH ;
RUDMAN, D .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1985, 42 (04) :577-584
[4]  
DURAN M, 1990, J CLIN CHEM CLIN BIO, V28, P359
[5]  
EDWARDS MA, 1987, LANCET, V1, P1437
[6]   MUSCLE CARNITINE REPLETION BY LONG-TERM CARNITINE SUPPLEMENTATION IN NEPHROPATHIC CYSTINOSIS [J].
GAHL, WA ;
BERNARDINI, IM ;
DALAKAS, MC ;
MARKELLO, TC ;
KRASNEWICH, DM ;
CHARNAS, LR .
PEDIATRIC RESEARCH, 1993, 34 (02) :115-119
[7]   ORAL CARNITINE THERAPY IN CHILDREN WITH CYSTINOSIS AND RENAL FANCONI SYNDROME [J].
GAHL, WA ;
BERNARDINI, I ;
DALAKAS, M ;
RIZZO, WB ;
HARPER, GS ;
HOEG, JM ;
HURKO, O ;
BERNAR, J .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :549-560
[8]   Carnitine metabolism in chronic liver disease [J].
Krahenbuhl, S .
LIFE SCIENCES, 1996, 59 (19) :1579-1599
[9]   Carnitine metabolism in patients with chronic liver disease [J].
Krahenbuhl, S ;
Reichen, J .
HEPATOLOGY, 1997, 25 (01) :148-153
[10]   CARDIOMYOPATHY IN FUMARYLACETOACETASE DEFICIENCY (HEREDITARY TYROSINEMIA) - A NEW FEATURE OF THE DISEASE [J].
LINDBLAD, B ;
FALLSTROM, SP ;
HOYER, S ;
NORDBORG, C ;
SOLYMAR, L ;
VELANDER, H .
JOURNAL OF INHERITED METABOLIC DISEASE, 1987, 10 :319-322